Sugi Predict
/ Targets
/ RPN2
Top predicted compounds (top 20 by supporting neighbours, then confidence)
| Compound | Confidence | Supporting neighbours |
|---|
Clinical trials — most relevant to RPN2 by text similarity (a relevance ranking, not an exhaustive list)
| Trial | Phase | Status |
|---|
| Management of Retinitis Pigmentosa Via Combination of Wharton's Jelly-derived Mesenchymal Stem Cells and Magnovision |
PHASE3 | COMPLETED |
| Phase II Study of Simvastatin Plus Irinotecan, Fluorouracil, and Leucovorin(FOLFIRI) for Metastatic CRC |
PHASE2 | COMPLETED |
| Mobilization of Stem Cells With G-CSF for Collection From Patients With Diamond-Blackfan Anemia |
PHASE2 | COMPLETED |
| 24-Week Study to Assess the PD, Safety, Tolerability, and PK of GLM101 in Participants With PMM2-CDG |
PHASE2 | COMPLETED |
| Investigating the Effect of Vitamin A Supplementation on Retinitis Pigmentosa |
PHASE1 | COMPLETED |
| MAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy Subjects (Wallaby) |
PHASE1 | COMPLETED |
| InsightRP2 Registry |
nan | RECRUITING |
| Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases |
nan | UNKNOWN |
| Genetic Investigations in Children With Developmental and Epileptic Encephalopathies in Ho Chi Minh City, Vietnam |
nan | UNKNOWN |
| Genetic Studies of Lysosomal Storage Disorders |
nan | ENROLLING_BY_INVITATION |
| Clinical Characterization on PDE6A-related Retinitis Pigmentosa in Preparation to a Gene Therapy Trial |
nan | COMPLETED |
| Biomarker for Hurler Disease (BioHurler) |
nan | WITHDRAWN |
| The Natural History of Alpha-Mannosidosis |
nan | COMPLETED |
| Protein Synthesis in the Brain of Patients With Fragile X Syndrome |
nan | COMPLETED |
| Clinical and Basic Investigations Into Hermansky-Pudlak Syndrome |
nan | RECRUITING |
| CoMPaSS-NMD - Computational Models for New Patients Stratification Strategies of HNMD |
nan | ENROLLING_BY_INVITATION |
| Gene Modifiers of Cystic Fibrosis Lung Disease |
nan | ACTIVE_NOT_RECRUITING |
| Glycosylation in Patients With Galactosaemia |
nan | COMPLETED |
| Using D-Galactose as a Food Supplement in Congenital Disorders of Glycosylation |
nan | COMPLETED |
| Biomarker for Patients With Fabry Disease (BioFabry) |
nan | WITHDRAWN |
| Effects of Subtenon-injected Autologous Platelet-rich Plasma on Visual Functions in Eyes With Retinitis Pigmentosa |
nan | COMPLETED |
| Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others |
nan | RECRUITING |
| Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic Variants |
nan | RECRUITING |
| Diagnosis of Primary Ciliary Dyskinesia |
nan | COMPLETED |
| Investigations of Juvenile Neuronal Ceroid Lipofuscinosis |
nan | RECRUITING |
| Long-read Genome Sequencing for the Molecular Diagnosis of Dystonia |
nan | RECRUITING |
| Registry Gangliosidoses |
nan | UNKNOWN |
| The LD Lync Study - Natural History Study of Lipodystrophy Syndromes |
nan | RECRUITING |
| Establishment of Human Cellular Disease Models for Wilson Disease |
nan | COMPLETED |
| Natural History of Glycosphingolipid Storage Disorders and Glycoprotein Disorders |
nan | RECRUITING |
Related proteins — ESM-2 sequence neighbours (a RPN2 binder may also engage these)